-
Aduhelm is the first treatment approved in the country to slow cognitive decline in those living with Alzheimer's. Doctors have refused to prescribe it, given the lack of data and evidence behind it.
-
Scientists have created detailed maps of the brain area that controls movement in mice, monkeys and people. The maps could help explain human ailments like Alzheimer's and Lou Gehrig's disease.
-
Some patients who have had COVID-19 develop symptoms resembling early Alzheimer's. Researchers are trying to figure out whether these people are more likely to develop the disease itself.
-
A plaque-busting Alzheimer's drug called Aduhelm has yet to prove it can preserve memory and thinking. Even so, its approval by the Food and Drug Administration is making some patients opitimistic.
-
In his resignation letter, Dr. Aaron Kesselheim calls it "probably the worst drug approval decision in recent U.S. history." An FDA official says the agency found the benefits outweighed the risks.
-
This is the first new drug approved for Alzheimer's disease since 2003. It's the first to show significant progress against the sticky brain plaques that are the hallmark of Alzheimer's disease.
-
Nonwhite Americans looking for care for a loved one are much more likely than whites to encounter discrimination, language barriers, and providers who lack cultural competence, a new report finds.
-
In a profile of the iconic 94-year-old singer for AARP The Magazine, Bennett's wife says he was diagnosed in 2016. While the disease progressed, he recorded a new album of duets with Lady Gaga.
-
Throughout the pandemic, seniors with Alzheimer’s have been some of the most at-risk Oklahomans and the measures taken to protect them come at a cost.Tom…
-
People who get more deep sleep appear less likely to develop Alzheimer's. That may be because this phase of sleep allows the brain to clear out waste products.